post Category: Uncategorized — asia pr news @ 3:52 am — post

RESEARCH TRIANGLE PARK, N.C., Oct. 30 /PRNewswire-AsiaNet/ –

Bio-Trials to Complement Existing Quintiles Latin American Organization

Quintiles Transnational Corp. today announced that its Latin American
subsidiary has purchased Bio-Trials, a leading Central American Clinical
Research Organization (CRO) with headquarters in Panama and offices in Costa
Rica, Guatemala, Ecuador and Peru.

Bio-Trials provides clinical monitoring, clinical site coordination,
regulatory support, study management and supply distribution services. It has
conducted about 30 clinical trials in 10 Central and South American countries,
and its customers have included a number of major pharmaceutical companies and
global CROs.

"The acquisition of Bio-Trials gives Quintiles an experienced,
well-established team as well as access to an experienced network of
independent investigators in the increasingly important Central American
region," said Jeff Thomis, President of Global Clinical Development Services
for Quintiles. "Our customers are increasingly including Central America as
part of their global drug development program. The Bio-Trials team will be a
welcome addition to our Latin America group."

In addition to its offices, Bio-Trials has supply distribution points in
Panama, Costa Rica, Guatemala and Peru.

About Quintiles Latin America
Quintiles Latin America was founded in 1995 and now has nearly 600
employees in six countries, with headquarters in Argentina, providing project
management, clinical trial monitoring, regulatory, drug safety, site
management, quality assurance, central laboratory and clinical trial supplies
services. Quintiles Latin America has conducted more than 300 studies involving
more than 30,000 patients.

About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation of healthcare
by providing a broad range of professional services in drug development,
financial partnering and commercialization for the pharmaceutical,
biotechnology and healthcare industries. With more than 19,000 employees and
offices in more than 50 countries, it is focused on providing customer-centric
solutions that are the gold standard of the industry. For more information,
please visit the company’s Web site at www.qtrn.com

SOURCE: Quintiles Transnational Corp.

CONTACT: Dick Jones,
Media Relations,
+1-919-998-2091,
media.info@quintiles.com, or

Greg Connors,
Investor Relations,
+1-919-998-2000,
invest@quintiles.com

Web site: http://www.qtrn.com

Sorry, comments are closed.